Louis M. Weiner is Vice President, Translational
Research and Chairman, Dept. of Medical Oncology, Fox Chase Cancer
Center, Philadelphia, PA 19111 and Paul
Carter is Senior Director, Antibody Technologies, Seattle Genetics,
Seattle, WA 98021
lm_weiner@fccc.edu; pcarter@seagen.com
A recent Keystone meeting highlighted the progress in developing
antibody-based therapeutics for cancer.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
